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Abstract.  Our previous immunofluorescence studies 
support the conclusion that the temporal appearance 
and subcellular distribution of TS28 (a marker of 
transverse (T) tubules and caveolae in adult skeletal 
muscle [Jorgensen, A. O., W. Arnold,  A. C.-Y. Shen, 
S. Yuan, M.  Gover, and K. P. Campbell.  1990.  J.  Cell 
Biol.  110:1173-1185]), correspond very closely to those 
of T-tubules forming de novo in developing rabbit 
skeletal muscle (Yuan,  S., W. Arnold,  and A. O. Jor- 
gensen.  1990.  J.  Ceil Biol.  110:1187-1198). 
To extend our morphological studies of the biogene- 
sis of T-tubules and triads,  the temporal appearance 
and subcellular distribution of the o~t-subunit of 
the  1,4-dihydropyridine receptor (a marker of the 
T-tubules and caveolae) was compared to (a) that of 
TS28; and (b) that of the ryanodine receptor (a marker 
of the junctional sarcoplasmic reticulum)  in rabbit 
skeletal muscle cells developing in situ (day 19 of 
gestation to  10 d newborn) by double immunofluores- 
cence labeling. 
The results presented show that the temporal appear- 
ance and relative subcellular distribution of the ct~-sub- 
unit of the  1,4-dihydropyridine receptor (otI-DHPR) 
are distinct from those of TS28 at the onset of the bio- 
genesis of T-tubules.  Thus,  in a particular developing 
myotube the al-DHPR appeared before TS28 (second- 
ary myotubes; day 19-24 of gestation).  Furthermore, 
the otI-DHPR was distributed in discrete foci at the 
outer zone of the cytosol, while TS28 was confined to 
foci and rod-like structures at the cell periphery.  As 
development proceeded (primary myotubes; day 24 of 
gestation)  ,050%  of the foci were positively labeled 
for both TS28 and the o~-DHPR, while ,020 and 30% 
of the foci were uniquely labeled for TS28 and the otl- 
DHPR, respectively. The foci labeled for both TS28 
and the t~1-DHPR and the foci uniquely labeled for 
TS28 were generally confined to the cell periphery, 
while the foci uniquely labeled for the aI-DHPR were 
mostly confined to the outer zone of the cytosol.  1-2 d 
after birth,  TS28 was distributed in a chickenwire- 
like network throughout the cytosol, while the ctm- 
DHPR was confined to cytosolic foci. In contrast, the 
temporal appearance and subcellular distribution of 
the o~m-DHPR and the ryanodine receptor were very 
similar,  if not identical,  throughout all the stages of 
the de novo biogenesis of T-tubules and triads ex- 
amined. 
Assuming that the subcellular distribution of TS28 
represents the distribution of forming T-tubules the 
results presented are consistent with the following 
plausible scheme for the biogenesis of T-tubules 
and triads.  Before the onset of T-tubule formation, 
otl-DHPR-containing cytosolic vesicles form a com- 
plex with a ryanodine receptor-containing  membrane 
system (c~rDHPR: ryanodine receptor-complex). This 
complex is distributed at the outer zone of the cyto- 
sol. After the onset of formation of TS28-containing 
T-tubules, the a~-DHPR ryanodine receptor-complex 
becomes incorporated into discrete regions of the 
forming T-tubules at the cell periphery.  Assuming that 
otrDHPR is complexed with the ryanodine receptor- 
containing membrane system, incorporation of the 
otrDHPR into T-tubules also results in the formation 
of a junctional complex between T-tubules and the sar- 
coplasmic reticulum. 
XCITATION-CONTRACTION coupling  in adult skeletal 
muscle depends on appropriate communication across 
the narrow gap between transverse  (T) tubules and 
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the junctional  sarcoplasmic  reticulum  (SR). t This  gap is 
bridged by regularly arranged electron dense structures called 
"feet"  (9).  Depolarization  of transverse  tubules results  in 
Ca  2÷ release from the lumen of the junctional SR, which in 
1. Abbreviations used in this paper: DHPR,  1,4-dihydropyridine receptor; 
SR, sarcoplasmic retieulurn. 
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from the T-tubules to the junctional SR is still unknown it 
is generally accepted that the 1,4-dihydropyridine  receptor 
(DHPR) (31) and the ryanodine receptor (6) are essential 
links in the excitation-contraction  coupling. 
Biochemical  (7)  and  immunoelectron  microscopical 
studies (16) have demonstrated that the DHPR is densely dis- 
tributed in the T-tubular  membrane.  The immunoeleetron 
microscopical studies also showed that the DHPR is present 
in subsarcolemmal vesicles possibly corresponding to caveo- 
lae (16). On the basis of  physiological (31) and molecular bio- 
logical (38, 39) studies it has been proposed that the DHPR 
functions as a voltage sensor in the excitation-contraction 
coupling  process.  Characterization  of the highly  purified 
DHPR (4, 5,  10) has shown that it is composed of at least 
five  polypeptide  components  including  the  ot~  (155-200 
kD), the a2 (150 kD,  reduced), the/~  (52 kD), the 3, (32 
kD), and the ~ (23-29 kD) subunits.  The ott-DHPR is the 
DHP binding  component of the DHPR. 
Immunoelectron microscopical localization  of a compo- 
nent of the junctional SR biochemically characterized as the 
foot protein demonstrated this protein to be localized in the 
region of the junctional complex between T-tubules and junc- 
tional  SR in skeletal  muscle (18). The rya odine receptor 
purified  from the junctional SR (12, 13, 25, 37) functions 
upon reconstitution  as the Ca2+-release channel  of the SR 
(12, 25, 37), and its structure (1, 25, 33, 43) corresponds to 
that of individual  foot structures  observed in freeze-fracture 
images of  junctional SR (1). Furthermore, the position of ev- 
ery other foot structure corresponds precisely to that of large 
diamond-shaped  clusters of integral  membrane particles in 
the closely apposed junctional T-tubule membrane (1). As- 
suming  that  these  clusters  correspond  to  DHPRs  (26), 
studies  by Block et al.  (1) suggested that the DHPR recep- 
tor/voltage sensor in the T-tubular membrane may complex 
with and, thus, activate the ryanodine receptor/Ca2+-release 
channel  of the SR directly. 
Despite the functional significance of the T-tubules and the 
junctional complex between the T-tubules and the junctional 
SR for excitation-contraction coupling  in skeletal  muscle, 
very little is known about the assembly of these structures. 
Ukrastructural studies have shown that de novo formation of 
the junctional complex occurs in developing  rabbit skeletal 
muscle between fetal  day 22 and  10 d after birth,  and is 
preceded by the onset of the formation of T-tubules which be- 
gins at fetal days  17-19 (21). 
An ultrastructural  study of the formation of T-tubules and 
SR in developing  rat skeletal  muscle in situ reported that 
forming T-tubules first appear as short tubular invaginations 
of the sarcolemma (19). At the same time, eaveolae were fre- 
quently encountered at the cell periphery and sometimes ob- 
served to be arranged  in clusters and short beaded tubular 
structures.  At the onset of their formation  T-tubules  were 
mostly present in the subsarcolemmal region  and oriented 
parallel to the longitudinal axis of the myofibers. As develop- 
ment proceeds the T-tubules branch, and extend further to- 
wards the interior regions of the myofibers, and their trans- 
verse orientation becomes more prominent (19, 34). Before 
the onset of T-tubular  formation  SR forms transient  junc- 
tional complexes with the sarcolemma (19). As T-tubule for- 
marion occurs the SR also forms focal junctional complexes 
with the forming T-tubules.  These internal junctional com- 
plexes are at first  located at the peripheral  regions of the 
cytosol, and only later as the T-tubules extend further toward 
the central regions of the myofibers are junctional complexes 
between T-tubules  and SR also observed in these regions. 
Only much later does the transverse orientation of the junc- 
tional complexes become prominent and junctional SR con- 
tinuous  along  the  entire  length  of the  now  transversely 
oriented T-tubules  (34).  As the formation  of interior june- 
tional  complexes  becomes more  extensive  the junctional 
complexes between SR and sarcolemma decrease dramati- 
cally (19). 
To begin to understand the molecular aspects of the bio- 
genesis of T-tubules we have recently used immunofluores- 
cence labeling techniques  to demonstrate that the temporal 
appearance  and  subcellular  distribution  of TS28  (45)  (a 
28-kD protein marker  of T-tubules  and caveolae  in adult 
skeletal  muscle distinct  from the DHPR [17]), correspond 
very closely to those of T-tubules  forming  de novo in de- 
veloping rabbit skeletal muscle (21). These results suggested 
that TS28 is an excellent marker of T-tubules from the onset 
of their formation in developing skeletal muscle and support 
the "add-on" model for the biogenesis of T-tubules first pro- 
posed by Schiaffino  et  al.  (35).  In  accordance with this 
model we proposed that to initiate the formation of a particu- 
lar T-tubule a TS28-containing  membrane vesicle fuses with 
the sarcolemma forming a TS28-containing  caveolae. How- 
ever, TS28 in the lipid bilayer of the caveolae is somehow 
prevented  from ditfusing  into the lateral regions of the sar- 
colemma.  Subsequently,  additional  TS28-contalning  vesi- 
cles fuse first  with the TS28-containing  caveola,  forming 
short tubular invaginations  in the subsarcolemmal region. 
Repeated fusions of TS28-containing  transfer  vesicles with 
the short TS28-containing  tubular structures result in the for- 
marion of further extended T-tubules (45). 
To further elucidate the sequence of events leading to the 
de novo biogenesis of functional  T-tubules,  double immu- 
nofluorescence labeling of rabbit skeletal muscle developing 
in situ was used to compare the temporal appearance and 
subcellular distribution  of the c~-DHPR to those of TS28 in 
developing  rabbit skeletal  muscle during  the de novo for- 
marion  of T-tubules  and  the junctional  complex between 
T-tubules and junctional SR called triads (day 19 of gestation 
to 10 d after birth). To begin to understand how the junc- 
tional complex between the T-tubules and the junctional SR 
assembles, the same approach was used to compare the tem- 
poral appearance and subcellular distribution  of TS28 and 
the ot1-DHPR to those of the ryanodine receptor, a marker 
of the junctional region  of the SR. 
The results of  these studies are consistent with the idea that 
before the  onset of T-tubule  formation,  aI-DHPRs  form 
complexes with ryanodine receptors which accumulate in the 
outer zone of the cytosol. After the onset of formation  of 
TS28-containing  T-tubules, the ot~-DHPR ryanodine  recep- 
tor complexes become incorporated into forming T-tubules, 
thus, possibly simultaneously incorporating  the DHPR into 
discrete regions  of the T-tubular membrane and forming a 
junctional complex between T-tubules and the SR. 
Materials and Methods 
Preparation of 7Issue Extract, Membrane 
Fractions, and Purification of  Proteins  from 
Rabbit Skeletal Muscle 
Skeletal muscle extracts represent the supernatant obtained by extracting 
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cle tissue was quickly dissected, frozen in liquid N2, and powdered with a 
precooled mortar and pestle. The muscle powder was extracted for 5 rain 
at room temperature with buffer A (10% SDS,  10 mM EDTA, 0.1 M Tris, 
50 mM DTT,  and 0.1 mM PMSF,  pH 8.0) at a ratio of 100 mg/ml (net 
weight/vol).  The extracts were centrifuged for 15 rain at 12,800 g (Eppen- 
doff centrifuge 5412; Brinkmann Instruments Co., Westbury, NY) and the 
supernatant was used immediately for SDS-PAGE. The DHPR was purified 
as  described by  Campbell and  Kahl  (3).  The  ryanodine  receptor  was 
purified as described by Imagawa et al. (12). Protein concentrations were 
determined by the method of Lowry et al. (27) as modified by Peterson (29) 
using BSA as a standard. 
Preparations and Characterization of  Monoclonal 
and Polyclonal  Antibodies 
TS28. IXEll2 to TS28  was prepared and characterized as previously  de- 
scribed (17). 
ct~-DHPR. Polyclonal  antibodies to  purified  DHPR  were  raised  in 
guinea pigs by a series of intraperitoneal injections  as described by Tung 
(41). The presence and specificity of antibodies to the cq-DHPR were de- 
termined by immunoblotting of SDS-PAGE-separated  skeletal  muscle ex- 
tract, purified DHPR, and ryanodine receptor.  Affinity-purified antibodies 
to the cq-DHPR from rabbit skeletal muscle were prepared from guinea 
pig ascites according to the methods of Fowler  and Bennet (8) using a 
DHPR-nitrocellulose paper complex (100 gg DHPR/square inch nitrocellu- 
lose paper) as the affinity column. 
Ryanodine Receptor. Polyclonal  antibodies to immunoaflinity-purified 
ryanodine receptor from rabbit skeletal muscle (12) were produced in sheep 
as previously described (23).  Briefly, antiserum was raised in a sheep by 
a series of intramuscular injections with 0.5 nag of purified ryanodine recep- 
tor. The presence and specificity of antibodies to the rabbit skeletal ryano- 
dine receptor was determined by immunoblotting  of SDS-PAGE-separated, 
purified  ryanodine receptor,  DHPR, and skeletal muscle extracts. 
Affinity-purified  antibodies to  the rabbit skeletal ryanodine receptor 
were prepared from sheep antiserum according to the procedure of Fowler 
and Bennetl (8) using a purified ryanodine receptor-nitrocellulose paper 
complex (100/~g ryanodine receptor/square inch nitrocellulose  paper) as the 
affinity column. 
lmmunoblotting 
SDS-PAGE was performed by the method of Laemmli (24) using either a 
7.5 % continuous polyacrylamide  separating gel or a discontinuous separat- 
ing gel where the top and bottom half of the separating polyacrylamide  gel 
was 3.0 and 7.5%, respectively.  Transelectrophoresis  of SDS-PAGE sepa- 
rated proteins onto nitrocellulose  and subsequent immunoblotting was per- 
formed according to the methods of Towbin et al. (40) with minor modifica- 
tion as outlined below. 
Nitrocellulose  blots were blocked in 5 % nonfat dry milk in TBS (20 mM 
TRIS,  500 mM NaCI,  pH 7.4) (14). The antibody incubation medium in- 
cluded 2.5% nonfat dry milk in TTBS (TBS containing 0.05% Tween 20). 
For immunoblotting of the DHPR, the blots were incubated for 1 h with 
guinea pig antibodies to the ,*I-DHPR  (1:1,000 dilution).  The blots were 
then washed to remove unbound antibody, incubated with affinity-purified 
goat anti-guinea pig IgG conjugated  to alkaline phosphatase (1:3,000 dilu- 
tion; Biorad Laboratories, Ltd., Richmond, CA) in 2.5% nonfat dry milk 
in TTBS. The blots were rinsed twice with TTBS for 5 rain each and TBS 
for 10 rain. Color development was completed using 5-Bromo-4-chloro-3- 
indolyl phosphate-toluidine salt (BCIP)/p-nitro blue tetrazolium chloride 
(NBT)  substrate  reagents  (BCIP/NBT;  Biorad  Laboratories  Ltd.).  All 
procedures were performed at room temperature with gentle agitation.  The 
reaction was terminated by thoroughly rinsing the blots with water and al- 
lowing them to air dry. Immunoblotting  with sheep antibodies to the ryano- 
dine receptor was carried out as described above except that a triple-layered 
procedure was  used.  Thus,  the incubation with sheep antibodies to the 
ryanodine receptor (1/500 dilution) was followed first by an incubation with 
affinity-purified goat anti-sheep IgG conjugated  to biotin (1:1,000 dilution; 
Biorad Laboratories Ltd.) and then by an incubation  with avidin-conjugated 
alkaline phosphatase (1:1,000 dilution; Biorad Laboratories Ltd.). 
Dissection, b~xation, and Cryosectioning 
Hind limb muscle tissues were dissected from rabbits at different stages of 
development ranging from day  19 of gestation to 2 d after birth. Bundles 
of myofibers from 10-d and adult rabbit gracilis muscle were dissected and 
tied to tooth picks at 100-120%  of rest length, fixed in 2% paraformalde- 
hyde, and infused with 0.6 M sucrose as previously  described (15). Small 
blocks of fixed and unfixed muscle tissues were cryofixed in isopentane, pre- 
cooled in liquid N2.  Cryostat sections (6-8 gin) were cut, fixed in 70% 
ethanol at 0°C for 5 rain, air dried, and stored in a desiccator at  -20°C 
until use. 
lndirect Immunofluorescence Labeling 
Single lmmunofluorescence Labeling. Immunofluorescence  labeling of 
6-8-#m cryosections of fixed and unfixed muscle tissues was carried out as 
previously  described (15). Briefly, the sections were first labeled with one 
of the following antibodies: (a) afffinity-purified  guinea pig antibodies to the 
cq-DHPR  (10 #g/ml);  (b) mAb IXEll2 to  TS28  (1.74 #g/ml);  and (c) 
affinity-purified sheep antibodies to the ryanodine receptor (10 #g/ml). The 
corresponding secondary antibodies were  (a) F(ab')2 fragments of rabbit 
anti-guinea pig IgG conjugated  to FITC  (1:40 dilution; Organon Teknika 
Co.,  West Chester,  PA);  (b) F(alY)2 fragments  of affinity-purified  rabbit 
anti-mouse  IgG  eonjngated to  rhodamine  (1:80  dilution;  Jackson  Im- 
munoresearch Laboratories Inc., West Grove,  PA);  and (c)  F(ab')2 frag- 
ments of affinity-purified  rabbit anti-sheep IgG conjugated  to fluorescein 
or rhodamine (1:40 dilution; Jackson Immunoreseareh Laboratories Inc.). 
Controls. For adsorption, 10 t~g/ml of affinity-purified antibodies to the 
DHPR was incubated with 0 and 60 #g/ml purified  DHPR as previously 
described (15).  Similarly,  10 v.g/ml of affinity-purified  antibodies to the 
ryanodine receptor was incubated with 0 and 60 gg/ml purified ryanodine 
receptor.  The molar ratio of antigen/antibody is "~2 for the adsorption of 
both antibodies.  The supernatants obtained by centrifugation were used as 
the primary reagent in the single indirect immunolabeling assay. 
Double lmraunofluorescence Labeling. Double  immunofluorescence 
labeling of 6-8-~m cryoseetions was carried out in sequential steps combin- 
ing two  of the three single immunofluorescence  labeling procedures de- 
scribed  above.  Double-labeling procedure  A  was  composed  of single- 
labeling procedure a for the cq-DHPR followed by labeling procedure b 
for TS28. Double labeling procedure B was composed of single labeling 
procedure a for the otI-DHPR  followed by procedure c for the ryanodine 
receptor where a rhodamine-conjugated  secondary antibody was used to la- 
bel the ryanodine receptor.  Double-labeling procedure C was composed of 
single-labeling procedure c for the ryanodine receptor followed by labeling 
procedure b for TS28. In procedure C, a fluorescein-eonjugated  secondary 
antibody was used to label the ryanodine receptor. 
Conventional fluorescence microscopy was carried out with a Zeiss pho- 
tomicroscope provided with an epifluorescence  attachment and a phase- 
contrast condenser. Confocal fluorescence microscopy was carried out with 
a Nikon photomicroseope provided with a Lasersharp MRC-500 confucal 
fluorescence imaging system, using a dual channel detection system and an 
Figure  1.  Characterization  of antibodies  to  the  DHPR  and  the 
ryanodine  receptor  by  immunoblotting.  Rabbit  muscle  extracts 
(A-C, lane 2; 5 gl)/purified DHPR (C, lane 1; 0.1 gg) and purified 
ryanodine receptor (A and B, lane 1; 4 #g) were prepared, separated 
by SDS-PAGE followed by immunoblotting with sheep antiserum 
to  the  ryanodine  receptor  (A)  and  guinea pig  antibodies to  the 
DHPR  (B and C) as described in Materials and Methods.  SDS- 
PAGE  of  the  lanes  shown  in  A  and  B  were  performed  using 
3 %/7.5 % discontinuous polyaerylamide as the separating gel. (The 
filled circle in A and B  indicate the border between the upper 3 % 
and the lower 7.5%  polyacrylamide gel.) SDS-PAGE of the lanes 
in C was performed using continuous 7.5 % polyacrylamide as the 
separating gel. 
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sauga, Canada) (44). The distribution of FITC-conjngated secondary anti- 
bodies was visualized by illumination with a laser line at 488 nm. The distri- 
bution of rhodamine-conjugated secondary antibodies was visualized by 
illumination with a laser line at 515 nm. The photographs were taken from 
an attached photo-recording system with high linearity. 
Analysis of the Relative Distribution of  arDHPR and 
TS28 in 24-d Fetal Skeletal Muscle 
Paired confocai images showing the relative  spatial  distribution of c~l- 
DHPR (see Fig. 4, c) and TS28 (see Fig. 4 d) in primary myofibers (n = 
15) present in transverse cryosections of 24-d fetal skeletal muscle double 
labeled for these two proteins were traced (see Fig. 4, e and  f) in two differ- 
ent colors (not shown) and superimposed. By superimposing the paired 
tracings, three distinct classes of fluorescenfly labeled foci were identified 
as illustrated in Fig. 4j. One class of foci were labeled for beth cq-DHPR 
and TS28 (see Fig. 4j, crosses),  another class of foci was uniquely labeled 
for cq-DHPR (see Fig. 4j, open circles),  while a third class was uniquely 
labeled for TS28  (see Fig. 4j, open triangles).  The sum of the number of 
foci in each of the three classes represents the total number of labeled foci 
in a particular cell. Next, the total foci and the foci in each of the three 
classes of foci were enumerated for each of the cells analyzed.  Subse- 
quently, the percentage of labeled foci in each of the three classes was calcu- 
lated for each cell. Finally, the percentage of foci in each class was averaged 
over the number of cells analyzed and an SD calculated. 
Results 
Characterization of  Antibodies to the DHPR and the 
Ryanodine Receptor 
The specificity of the sheep antiserum towards the ryanodine 
receptor purified  from  rabbit  skeletal  muscle  triads  was 
demonstrated by immunoblotting  of SDS-PAGE-separated 
ryanodine  receptor and  tissue extract  from rabbit skeletal 
muscle (Fig.  1 A). The sheep antiserum bound to a single 
band present in the muscle extract  (Fig.  1 A, lane 2). The 
electrophoretic  mobility of this band corresponds to that of 
the ryanodine receptor purified from rabbit skeletal muscle 
(Fig.  1 A, lane/). Furthermore, the sheep antiserum to the 
ryanodine receptor did not bind to the o~-DHPR also pres- 
ent in the muscle extract (Fig. 1 A, lane 2, arrow) as demon- 
strated by immunoblotting  of the same extract with antibod- 
ies to the a1-DHPR (Fig.  1 B, lane 2). 
Similarly,  the specificity  of the ascites  from guinea pigs 
immunized  with purified DHPR towards the a~-DHPR was 
demonstrated by immunoblotting  of SDS-PAGE-separated 
DHPR (Fig. 1 C, lane/), tissue extracts (Fig. 1 B, lane 2 and 
Fig. 1 C, lane 2), and ryanodine receptor from rabbit skele- 
tal muscle (Fig.  1 B, lane/).  The guinea pig antibodies  to 
the DHPR bound to a single band with an apparent  Mr of 
170,000 D present in the muscle extract (Fig. 1 B, lane 2 and 
1 C, lane 2). The electrophoretic mobility of the 170,000-D 
band in the muscle extract (Fig.  1 C, lane 2) corresponds to 
that of the o~I-DHPR  of the DHPR purified from rabbit skele- 
tal muscle (Fig.  1 C, lane/). However, the guinea pig anti- 
bodies did not bind to either the purified ryanodine receptor 
(Fig.  1 B, lane/) or to the ryanodine receptor present in the 
muscle extract (Fig. 1 B, lane 2), as demonstrated by immu- 
noblotting  of the same extract with sheep antibodies  to the 
ryanodine  receptor (Fig.  1 A, lane 2). 
These results  show that the guinea  pig antibodies  to the 
DHPR specifically bind to the c~-DHPR of the DHPR and 
that they do not cross react with the ryanodine receptor. They 
also show that the sheep antiserum to the ryanodine receptor 
is specific for the ryanodine receptor and does not cross react 
with the ot~-DHPR. 
SubceUular Distribution of the a~-DHPR, 
the Ryanodine Receptor, and TS28 in Skeletal Muscle 
Developing In Situ 
To determine the temporal appearance and subceUular distri- 
bution of the DHPR in relation to that of TS28, the subeellu- 
lar distribution  of the ot~-DHPR was compared to that  of 
TS28 in skeletal  muscle developing  in situ by double im- 
munofluorescence  labeling (day 19 of gestation to 15 d after 
birth). To determine temporal appearance and the subcellular 
distribution  of the junctional complex between the T-tubules 
and  the junctional  SR assumed to represent the forming 
triad,  the temporal appearance and subcellular distribution 
of the o~rDHPR and of TS28 were also compared to that of 
the ryanodine receptor by double immunofluorescence  label- 
ing of cryosections from rabbit skeletal  muscle developing 
in situ. 
Fetal Day 19-24 
A mixture of myofibers with large and small diameters  was 
observed in transverse sections at this stage of development. 
We assume that the large and small myofibers correspond to 
"primary" and "secondary" myotubes, respectively, as previ- 
ously described in developing rat (20) and chick (28) skeletal 
muscle. Since the developmental  stage of primary myotubes 
is ahead of that of the surrounding  "secondary" myotubes, a 
mixture  of myofibers at various  stages of development  is 
present in sections from rabbit hind limbs between fetal day 
19 and day 24 of gestation. 
aI-DHPR versus TS2g  Examination  of transverse  cryo- 
sections  from 19-24-d-old fetal rabbit skeletal  muscle fol- 
lowing double labeling  for the ot1-DHPR (Fig.  2, a  and c) 
and  for TS28  (Fig.  2,  b  and d)  showed  that  labeling  for 
the o~I-DHPR  was present in all large primary (Fig. 2 a, ar- 
rows) and all small secondary myotubes (Fig. 2 a, single and 
double arrowheads), while that for TS28 was present in all 
primary myotubes (Fig. 2 b, arrows) and some (Fig. 2 b, sin- 
gle arrowhead) but not all small secondary myotubes (Fig. 
2  b,  double  arrowheads).  The labeling  for the ol1-DHPR 
was distributed  in discrete foci present at both the cell pe- 
riphery and the interior  regions  of both primary (Fig. 2, a 
and c, arrows) and secondary myotubes (Fig. 2, a and c, sin- 
gle and double arrowheads). In contrast,  TS28 as previously 
shown (45) was mostly confined to foci and rod-like  struc- 
tures at the cell periphery of  the corresponding primary myo- 
tubes (Fig.  2, b and d, arrows), and some (Fig.  2, b and 
d, single arrowheads) but not all secondary myotubes (Fig. 
2 b, double arrowheads). However, at this stage of develop- 
ment foci and rod-like structures positively labeled for TS28 
were also present in the outer regions of the cytosol of some 
primary myofibers (Fig. 2 d, arrow). The results presented 
suggest that the first appearance of the o~t-DHPR in second- 
ary myotube precedes that of TS28. Furthermore, it is partic- 
ularly obvious that the distribution of a considerable propor- 
tion  of foci  at  the cell periphery  of myotubes positively 
labeled for the cq-DHPR (Fig.  2,  a  and c,  single arrow- 
heads) is distinct from that of the foci and rod-like structures 
at the periphery of the corresponding myotubes positively la- 
beled for TS28 (Fig.  2, b and d, single arrowheads).  The 
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cq-DHPR,  the  ryanodine  re- 
ceptor, and TS28 in transverse 
cryosecfions  of unfixed  19- 
24-d-old  fetal rabbit  skeletal 
muscle  by  conventional  im- 
munofluorescence  microscopy. 
Transverse sections were dou- 
ble  immunolabeled  with  (/) 
affinity-purified antibodies to 
the  cq-DHPR  (a  and  c)  and 
with mAb IXEll2 to TS28 (b 
and d) (procedure A); (2) af- 
finity-purified  antibodies  to 
the  oq-DHPR (e and g)  and 
with affinity-purified  antibod- 
ies to the ryanodine receptor 
(land  h)  (procedure B);  and 
(3)  affinity-purified  antibod- 
ies  to  the  ryanodine  recep- 
tor (i  and k)  and  with  mAb 
IXEll2 to TS28 (j and l) (pro- 
cedure  C).  Specific  labeling 
for  TS28  is  present  in  all 
primary  myotubes  (b  and j, 
arrows)  and  some  (b,  single 
arrowhead) but not all secon- 
dary myotubes (b and j, dou- 
b/e antnCw.ads).  TS28 labeling 
in primary and some second- 
ary  myotubes  is  confined  to 
discrete foci or rod-like struc- 
tures at the cell periphery (b, 
d, j, and l; arrows and single 
arrowheads).  These  rod-like 
structures extend from the cell 
periphery towards the  center 
of the cell in some myotubes 
(d, arrowhead and l; arrows). 
In contrast,  specific labeling 
for both the cq-DHPR (a, c, e 
and g) and the ryanodine re- 
ceptor ~  h, i, and k) is pres- 
ent in discrete foci in the outer 
zone of  the cytosol in both pri- 
mary and secondary myotubes 
(a and e, f  and i; arrows,  sin- 
gle and double arrowheads). 
It  is  noteworthy  that  most 
of the foci labeled for the c~- 
DHPR (e and g) are also la- 
beled for the ryanodine recep- 
tor (fand h).  Bars, 5/~m. 
possibility that lack of TS28 labeling of ot~-DHPR-positive 
foci is due  to steric hindrance  is highly  unlikely  since the 
same results were obtained when labeling for TS28 preceded 
that for o~-DHPR in the double immunofluorescence label- 
ing experiments. 
Examination of longitudinal  cryosections from  19-24-d- 
old fetal rabbit skeletal muscle following double labeling for 
the ~-DHPR  (Fig.  3 a) and for TS28 (Fig.  3 b) confirmed 
the results obtained by double labeling of transverse sections 
(Fig. 2, a-d). Thus, labeling for the cq-DHPR was localized 
Yuan et al. Biogenesis of Transverse Tubules  293 Figure 3. Localization  of the cq-DHPR, the ryanodine  receptor, and TS28 in longitudinal  cryosections of unfixed 19-24-d-old fetal rabbit 
skeletal muscle by conventional  immunofluoreseence  microscopy. A longitudinal section was double immunolabeled (procedure A) with 
afffinity-purified  antibodies to the ~-DHPR (a) and mAb IXEII2 to TS28 (b) by the indirect immunofluoreseenee  labeling technique (see 
Materials and Methods). Similarly, a longitudinal section was double immunolabeled (procedure B) with afffinity-purified  antibodies to 
the ~-DHPR (c) and the ryanodine receptor (d). Specific labeling for the a~-DHPR is present as discrete foei in the outer zone of the 
cytosol (a and c). Most of the loci irnmunolabeled for the ~xt-DHPR (c) are also labeled for the ryanodine receptor (d).  In contrast, 
specific labeling of TS28 is mostly present at the cell periphery (b). Bars, 5/~m. 
to discrete foci present at both the cell periphery and the 
outer zone of the cytosol (Fig. 3 a), while the labeling for 
TS28 was mostly confined to the cell periphery (Fig. 3 b). 
These results imply that the o~t-DI-IPR and TS28  may in 
part colocalize at the cell periphery and that the at-DHPR 
is present in discrete foci in the central region of  the develop- 
ing myotube where TS28-containing T-tubules  are not yet 
present. 
aI-DHPR versus Ryanodine Receptor.  Examination of 
transverse sections double labeled for the ot~-DHPR (Fig. 
2, e and g) and for the ryanodine receptor (Fig. 2, land h) 
showed that specific labeling for both proteins was present 
in discrete foci in the outer zone of the cytosol of both pri- 
mary (Fig. 2, e and  f, arrows) and secondary myotubes (Fig. 
2, e and f, arrowheads). Furthermore, it was observed that 
a majority of the foci labeled for the ¢~-DHPR in both pri- 
mary (Fig. 2, e and g, arrows) and secondary myotubes (Fig. 
2, e and g, arrowheads) was also labeled for the ryanodine 
receptor (Fig. 2, land h; arrows and arrowheads,  respec- 
tively). 
Examination of longitudinal cryosection from 19-24-d fe- 
tal rabbit skeletal muscle following double labeling for the 
cx~-DHPR (Fig. 3 c) and for the .ryanodine receptor (Fig. 3 
d) confirmed the results obtained by double labeling of  trans- 
verse sections (Fig. 2, e-h). Thus, the distribution of label- 
ing for the ~-DHPR present in discrete foci in the cytosol 
(Fig. 3 c) corresponded very closely to that of the ryanodine 
receptor (Fig. 3 d). 
Ryanodine Receptor versus TS2& Examination of trans- 
verse  sections  double  labeled for the ryanodine receptor 
(Fig. 2, i and k) and for TS28 (Fig. 2, j  and l) showed that 
positive labeling for the ryanodine receptor was present in 
all primary (Fig. 2, i and k, arrows) and secondary myotubes 
(Fig. 2, i and k, double arrowheads), while that for TS28 was 
present in all primary myotubes (Fig. 2, j and 1, arrows) and 
some (not shown) but not all secondary myotubes (Fig. 2, 
j  and l, double arrowheads). These results indicate that the 
first appearance of  the ryanodine  receptor in a particular sec- 
ondary myotube precedes that of TS28. As expected on the 
basis of the results presented above (Fig. 2, b, d, f, and h), 
specific labeling for the ryanodine receptor in primary myo- 
tubes was present in discrete foci in the outer zone of the 
cytosol (Fig. 2, i and k), while specific labeling for TS28 was 
mostly confined to discrete foei and rod-like structures at the 
cell periphery (Fig. 2, j  and l). 
Confocal  Imaging of oo-DHPR versus  TS2& To corn- 
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and TS28 in transverse sections from 24-d- 
old  fetal  skeletal  muscle  by confocal  mi- 
croscopy. A 6-8-~,m transverse cryosection 
of unfixed 24-d-old  fetal  skeletal  muscle 
was double immunolabeled  (procedure  A) 
with  affinity-purified  antibodies  to  the 
cq-DHPR (a and c) and with mAb IXEll2 
to TS28 (b and d), and examined by confo- 
cal  microscopy  (0.2-/~m optical  section). 
Specific labeling for both the cq-DHPR (a 
and c) and for TS28 (b and d) is present in 
discrete foci. The foci positively labeled for 
the ~q-DHPR are distributed  at the cell pe- 
riphery and  outer zone  of the  cytosol  of 
primary  (a and c, arrows)  and  secondary 
myotubes (a, single and double arrowheads). 
In contrast,  loci strongly labeled for TS28 
are almost exclusively distributed at the cell 
periphery of primary myotubes (b and d, 
arrows).  Occasionally, faintly labeled foci 
are observed at the cell periphery of some 
secondary myotubes (b, single arrowhead). 
Other  secondary  myotubes  positively  la- 
beled for the c~l-subunit (a, double arrow- 
head) are not laoeled for TS28 (b, double 
arrowhead).  Tracings  of the  subcellular 
distribution of foci in the t~  primary myo- 
tubes  positively labeled  for the cq-DHPR 
(c) TS28 (d) are shown in e and f  (black 
dots), respectively. Superimposing the trac- 
ings shown in e andfidentifies three classes 
of foci:  (/)  foci  uniquely  labeled  for cq- 
DHPR  (g  and j  [open  circles]);  (2)  foci 
uniquely labeled for TS28 (h andj [open tri- 
angles]);  and (3) foci labeled for both al- 
DHPR and TS28 (i and j, crosses).  Com- 
parison  between the spatial distribution  of 
these three classes of foci as presented inj 
shows that  foci  uniquely  labeled  for cq- 
DHPR are usually present in the outer zone 
of the cytosol (j,  open circles),  while foci 
uniquely labeled for TS28 are mostly pres- 
ent at the cell periphery (], open triangles). 
The foci  labeled  for both the  czt-subunit 
and the TS28 are also mainly distributed in 
the cell periphery (j, crosses).  Bars, 5/~m. 
pare in more detail the distribution  of the c~1-DHPR (Fig. 
2, a  and c) and TS28 (Fig. 2, b  and d) at the early stages 
of  formation of  T-tubules (19-24 day of gestation), transverse 
sections double labeled for both proteins were examined by 
confocal microscopy which provides a Z-axis resolution of 
',~0.8/~m (2).  Fig. 4  shows confocal images of thin optical 
sections  from the  central  region  of a  6-8-~m  transverse 
cryosection of 24-d-old fetal skeletal muscle double labeled 
for the ott-DHPR (Fig. 4, a  and c) and for TS28 (Fig. 4, b 
and d). Generally, the images obtained in confocal micros- 
copy were  similar to  those  obtained  by conventional  im- 
munofluorescence microscopy. Thus,  it was observed that 
positive labeling for both the o,-DHPR (Fig.  4,  a  and  c) 
and for TS28 (Fig. 4, b and d) was distributed in discrete foci 
of all primary (Fig. 4, a-d, arrows) and secondary myotubes 
(Fig. 4, a  and b; single arrowhead).  Other secondary myo- 
tubes were also labeled for the al-DHPR (Fig. 4 a, double 
arrowhead), but not for TS28 (Fig. 4 b, double arrowhead). 
It is noteworthy, however, that a much higher proportion of 
the foci positively labeled for TS28 was confined to the cell 
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t~rDHPR,  the  ryanodine re- 
ceptor,  and  TS28  in  trans- 
verse cryosections of unfixed 
1-2  d  newborn  rabbit  skel- 
etal  muscle  by  conventional 
immunofluorescence  micros- 
copy. Transverse sections were 
double  immunolabeled  with 
(1) afffinity-purified  antibodies 
to the Otl-DHPR (a and c) and 
with mAb IXEll2 to TS28 (b 
and  d)  (procedure  A);  (2) 
affinity-purified  antibodies  to 
the  txI-DHPR  (e and g) and 
with affinity-purified  antibod- 
ies to the ryanodine receptor 
(f and h) (procedure B); and 
(3) affinity-purified antibodies 
to  the  ryanodine  receptor  (i 
and k) and with mAb IXEII2 
to TS28  (j and l) (procedure 
C). Specific labeling for TS28 
is distributed in a chickenwire- 
like  network  throughout  the 
cytosol (b, d,j, and l). In con- 
trast, specific labeling  for the 
tx1-DHPR  (a,  c,  e,  and  g) 
and for the ryanodine receptor 
(f,  h,  i,  and  k)  are  mostly 
confined to discrete  foci pres- 
ent  throughout  the  cytosol. 
The  subcellular  distribution 
of  loci  labeled  for  the  Ctl- 
DHPR (e and g, arrowhead) 
corresponds  very  closely  to 
that of the foci labeled  for the 
ryanodine receptor (f and h, 
arrowhead).  Bars,  5 #m. 
The Journal of Cell Biology, Volume 112, 1991  296 Figure 6.  Localization of the cq-DHPR, the ryanodine receptor, 
and TS28 in longitudinal cryosections of unfixed 1-2<i newborn 
rabbit skeletal muscle by conventional immunofluorescence  mi- 
croscopy. Longitudinal sections were immunolabeled  with affinity- 
purified antibodies to the c~t-DHPR (a and b), with mAb IXEll2 
to TS28 (c, d, and e), and with affinity-purified  antibodies to the 
ryanodine  receptor (fand g, arrow indicates approximate  longitudi- 
nal orientation of myotube). Specific labeling for TS28 is dis- 
tributed in an anastomosing network composed of both longitudi- 
nally and transversely oriented fiber-like structures (c, d, and e). 
In contrast, specific labeling for either the cq-DHPR (a and b) or 
the ryanodine receptor (land g) is present in discrete loci through- 
out the cytoplasm of the myofibers. Bars, 5 #m. 
periphery when transverse sections were imaged by confocal 
microscopy (Fig. 4, b and d) than when imaged by conven- 
tional epifluorescence microscopy (Fig. 2, b, d, j, and l). 
This is probably to some extent due to the fact that imaging 
of slightly oblique 6-8-/zm transverse sections of small myo- 
tubes by conventional microscopy could make it appear as 
if some of the peripherally located foci were present in the 
outer regions of the cytosol. 
To determine more precisely the spatial distribution of the 
fluorescent foci positively labeled for ot~-DHPR (Fig. 4 c) 
and TS28 (Fig. 4 d) in 24-d fetal primary myotubes, tracings 
of the foci labeled for ot~-DHPR (Fig. 4 e) and TS28 (Fig. 
4f) were superimposed (Fig. 4j).  Examination of the su- 
perimposed tracings (Fig. 4j) revealed three classes of foci, 
namely (a)  foci uniquely labeled for ot1-DHPR (Fig. 4, g 
and j, open circles);  (b) foci uniquely labeled for TS28 (Fig. 
4, h and j, open triangles); and (c) foci labeled for both ot~- 
DHPR and TS28  (Fig. 4, i and j, crosses).  Analysis of su- 
perimposed tracings of the distribution of fluorescent foci in 
primary myotubes (n =  15) present in transverse sections of 
24-d fetal muscle double labeled for the ot~-DHPR and for 
TS28 by confocal microscopy showed that 47 +  15 % of the 
foci were labeled for both the cq-DHPR and TS28, while 21 
+  10% and 31  +  12% of the foci were uniquely labeled for 
TS28  and the o~-DHPR, respectively. Furthermore, quali- 
tative examination of the spatial distribution of the three 
classes of foci showed that many of the foci uniquely labeled 
for the cq-DHPR were distributed in the outer zone of the 
cytosol (Fig. 4j, open circles), while the foci either uniquely 
labeled for TS28 (Fig. 4j, open triangles) or labeled for both 
the at-DHPR and TS28  (Fig. 4 j, crosses) were generally 
confined to the cell periphery. The considerable variability 
in the number of foci in the three subclasses is most likely 
due to the fact that individual primary myotubes in 24-d fetal 
skeletal muscle are at somewhat different stages of develop- 
ment. However,  a more extensive analysis will be required 
to determine if this is the case. 
Newborn 1-2 d 
aI-DHPR versus TS2g  Examination of transverse sections 
double labeled for the otl-DHPR (Fig.  5, a  and c) and for 
TS28 (Fig. 5, b and d) showed that all myofibers were posi- 
tively labeled for both proteins. The otrDHPR was mostly 
confined to discrete foci present throughout the cytosol (Fig. 
5, a  and c).  Occasionally, some foci appeared to be con- 
netted with faint fluorescent strands (Fig. 5, a arid c). In con- 
trast, TS28 was distributed in a chickenwire-like network 
present throughout the cytosol (Fig. 5, b and d). While the 
ot~-DHPR might codistribute with TS28 in parts of the TS28 
positively labeled network, it appears that ot~-DHPR is not 
uniformly distributed in this network. 
¢e1-DHPR  versus Ryanodine  Receptor.  Examination of 
transverse sections double labeled for the cel-DHPR (Fig. 5, 
e  and g) and for the ryanodine receptor (Fig.  5, f  and h) 
showed that the labeling for the ryanodine receptor (Fig. 5, 
f  and h) and the ¢x~-DHPR was confined to discrete foci 
present throughout the cytosol. Furthermore, the distribu- 
tion of most of the foci positively labeled for the ryanodine 
receptor  (e.g.,  Fig.  5  h,  arrowheads)  corresponded very 
closely to that of the foci positively labeled for the ce~-DHPR 
(Fig. 5 g, arrowheads). These results suggest that the ryano- 
dine receptor and the c~t-DHPR also colocalize at this stage 
of development. 
Ryanodine Receptor versus TS2g  Examination of trans- 
verse sections at this stage of  development double labeled for 
the ryanodine receptor (Fig. 5, i and k) and for TS28  (Fig. 
5, j  and l) confirmed the results described above.  Thus, as 
shown in Fig. 5 b, TS28 was distributed in a chickenwire-like 
network present throughout the cytosol (Fig. 5, j  and l). In 
contrast, the ryanodine receptor was mostly confined to dis- 
crete foci throughout the cytosol of all myofibers (Fig. 5, i 
and k). 
Examination of longitudinal sections labeled for either the 
c~-DHPR (Fig. 6, a  and b), or for the ryanodine receptor 
(Fig. 6, fand g), showed that the distribution of labeling for 
the ot~-DPHR and the ryanodine receptor was confined to 
discrete foci present throughout the cytosol. Occasionally, 
these foci appeared to be aligned in rows oriented more or 
less parallel to the longitudinal axis of the myofiber (Fig. 6 
b;  ~1-DHPR;  and Fig.  6  g;  ryanodine receptor).  In con- 
trast, labeling for TS28 appeared as previously reported (45) 
to be distributed in an anastomosing network (Fig. 6, c-e). 
The longitudinally oriented component of the anastomosing 
network is more prominent than the transversely oriented 
component at this stage of development (Fig. 6, d and e). 
Newborn 10 d and Adult 
Examination of longitudinal cryosections from 10-d (Fig. 7, 
Yuan et al. Biogenesis of Transverse Tubules  297 Figure 7. Localization  of the ¢Xl-DHPR, the ryanodine receptor, and TS28 in longitudinal  cryoseetions of fixed 10-d and adult rabbit skele- 
tal muscle by conventional  immunofluoreseence  microscopy. Longitudinal eryoseetions of paraformaldehyde  (2%) fixed 10-d-old (a, b, 
and c) and adult rabbit graeilis muscle (d-j) were labeled with affinity-purified  antibodies to the ~t-DHPR (a, d, and h), with mAb 
IXEI12 to TS28 (b and e), with affinity-purified  antibodies to the ryanodine receptor (c,f, and i), with affinity-purified  antibodies to the 
c~I-DHPR preadsorped with purified DHPR (g), and with affinity-purified  antibodies to the ryanodine receptor preadsorped with purified 
ryanodine receptor (j). Specific labeling of 10-d-old (a-c) and adult skeletal muscle sections (d-f, h and i) for the ¢x1-DHPR (a, d, and 
h), TS28 (b and e) and ryanodine receptor (c,f, and i) appears as transversely oriented strands at the junction between the A- and 1-bands 
as determined by phase-contrast microscopy (not shown). The specific fluorescence  labeling for the c~rDHPR seen in d and for the ryano- 
dine receptor seen infis greatly reduced after the preadsorption of these antibodies with purified DHPR (g) and ryanodine receptor (j), 
respectively. Arrows in h and i point to the position of A-I junctions in these fibers. Bars, 5 #m. 
a-c) and adult gracilis muscle (Fig. 7, d-j) immunolabeled 
for the otrDHPR (Fig. 7, a, d, and h), TS28  (Fig. 7, b and 
e), and the ryanodine receptor (Fig. 7, c, f, and i), showed 
that at both stages of development the distribution of the 
specific labeling for all three antibodies was indistinguish- 
able and generally confined to transversely oriented strands 
positioned at the A-I junction as determined by imaging the 
same field  by phase-contrast microscopy (results not shown). 
The specific fluorescence labeling for the ctt-DHPR (Fig. 7 
h, arrows) and for the ryanodine receptor (Fig. 7 i, arrows) 
sometimes appeared as a transversely oriented row of small 
bright  foci at the A-I junctions in  adult skeletal muscle 
fibers. When the antibodies to the ct~-DHPR and the ryano- 
dine receptor were preadsorbed with highly purified DHPR 
and the ryanodine receptor, respectively, the specific label- 
ing  for  the  ctrDI-IPR  (Fig.  7  d)  and  for  the  ryanodine 
receptor (Fig.  7 f) was greatly reduced (Fig.  7, g  and j, 
respectively). 
Discussion 
To assess at the cellular level whether the T-tubular proteins 
ott-DHPR and TS28 are incorporated simultaneously or se- 
quentially into forming T-tubules we have used double im- 
munofluorescenee labeling to compare the temporal appear- 
ance  and  subeellular  distribution  of  TS28  to  those  of 
oL~-DHPR during the de novo biogenesis of T-tubules and 
triads in skeletal muscle developing in situ. On the basis of 
our previous immunofluorescence studies (45)  we assume 
that the temporal appearance and subeellular distribution of 
TS28  represent those of forming T-tubules. 
We conclude that in a particular developing myotube the 
arDHPR appears before the onset of  formation ofT-tubules. 
This conclusion is supported by the results showing that pos- 
itive labeling for TS28 was not detectable in some of  the sec- 
ondary myotubes in 19-24-d fetal muscle positively labeled 
for a1-DHPR and is in agreement with results of previous 
studies on the ontogenesis of the DHPR in developing skele- 
tal muscle (32, 36, 42) showing that a large increase in the 
number of nitrendipine binding sites  (32,  36)  and in the 
amount of mRNA of the al-DHPR (42) are concurrent with 
fusion of myoblasts into myotubes. 
We also conclude that the subceUular distribution of a~- 
DHPR  and  TS28  are  generally distinct during the early 
stages of T-tubule formation. Thus, specific labeling for otl- 
DHPR is distributed at the cell periphery and the outer zone 
of the cytosol of all myotubes while TS28  as previously 
shown (45) is confined to discrete foci at the cell periphery 
when it first appears. Subsequently, TS28 was in contrast to 
otrDHPR  also  present  in  rod-like  structures  projecting 
from the cell periphery towards the interior regions of the 
cytosol.  Since  otI-DHPR  is  a  membrane  protein,  these 
results are consistent with the idea that at early stages of  myo- 
tube development the otl-DHPR is first synthesized and in- 
corporated into membrane-bound vesicles (Fig. 8; ,4/) that 
accumulate in the cytosol before the onset of T-tubule forma- 
tion. This interpretation is also consistent with results pre- 
sented by Romey et al. (32) showing that the level of DHPR 
((+)-methyl-[3H] PN 200-110 binding sites) in developing 
myotubes in culture reached its maximal level 2 d before the 
onset of T-tubule  formation as assessed by EM and the ap- 
pearance of spontaneous contractions. The subsequent pres- 
ence of TS28, but not ot~-DHPR, in rod-like structures sup- 
ports the idea that TS28 is fairly uniformly distributed in 
short tubular invaginations of  the sarcolemma corresponding 
to forming T-tubules,  while some o.-DHPR-containing ves- 
icles at the cell periphery become incorporated into discrete 
regions of forming T-tubules,  and other ott-DHPR-contain- 
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SKELETAL  MUSCLE 
F/gum  & One plausible scheme 
for the biogenesis of T-tubules 
and triads in developing  skele- 
tal  muscle. First,  ~m-DHPR 
(A/) and ryanodine receptors 
(B1) are assumed to be syn- 
thesized on membrane-bound 
polyribosomes,  incorporated 
into unique transfer vesicles, 
and distributed (.42 and 172, 
respectively).  Next,  TS28- 
containing vesicles (el) fuse 
first with the sarcolemma to 
form  a  caveolae (C2).  Se- 
quential fusions of TS28-eon- 
taining vesicles to the caveo- 
lae result in the formation of a 
tubular invagination into the 
myotube  (C3-C5). As this oc- 
curs, ryanodine receptor-con- 
taining vesicles are incorpo- 
rated into forming SR (B3), 
followed by complex forma- 
tion between ryanodine recep- 
tors in SR and the arDHPR-containing transfer vesicles (AB4) in the outer zone 0f the cytosol. In turn, the a~-DHPR-containing vesicle 
of this complex fuses with the TS28-containing forming T-tubules (ABC6), thus, incorporating the am-DHPR-containing  vesicles into a 
discrete region of the forming T-tubules (ABCT) and forming a junctional complex between the T-tubule and the SR. 
ing vesicles remain in the outer zone of the cytosol. This in- 
terpretation implies that otrDHPRs  are  not incorporated 
into forming T-tubules  until after the biogenesis of TS28- 
containing T-tubules  has begun. 
This interpretation was further supported by analysis of 
tracings of confocal images of 24-d fetal muscle double la- 
beled for TS28  and o~I-DHPR showing that '~50%  (47  + 
15%) of the foci in primary myotubes were labeled for both 
the c~I-DHPR and TS28. Of the remaining loci, '~30% (31 
+  12%)  were  uniquely  labeled  for  the  o~-DHPR,  and 
'~20% (21 +  10%) uniquely labeled for TS28. These results 
support the idea that only 60%  of the al-DHPR-labeled 
foci are incorporated into T-tubules at this stage of develop- 
ment. The finding that most of  the foci labeled for both TS28 
and the at-DHPR are confined to the cell periphery and 
most of the foci uniquely labeled for the at-DHPR are in 
the outer zone of the cytosol is consistent with the idea that 
the ~q-DHPR at the cell periphery are incorporated into 
TS28 containing forming T-tubules (45) previously shown to 
be oriented parallel or obliquely to the long axis of the myo- 
tube (19, 34) at the cell periphery, and that the foci uniquely 
labeled for the  o~1-DHPR represent  ot|-DHPR-containing 
membrane vesicles in the outer zone of the cytosol where 
TS28-containing T-tubules  are not yet present. The finding 
that most of the foci uniquely labeled for TS28 are confined 
to the cell periphery supports our previous proposal (45) that 
these loci may represent TS28-containing caveolae, or trans- 
verse and oblique sections of TS28-containing tubular struc- 
tures at the cell periphery lacking the otI-DHPR. 
In myotubes from 1- to 2-d-old rabbit skeletal muscle, 
TS28, as previously shown (45), was distributed in a chicken- 
wire-like network in transverse sections and as an anasto- 
mosing  network in  longitudinal sections,  suggesting that 
TS28 is uniformly distributed in both transverse and longitu- 
dinally oriented  T-tubules.  In  contrast,  most  of the  ot~- 
DHPR is distributed in discrete foci throughout the cytosol 
at this stage of development, indicating that ot1-DHPRs are 
incorporated into discrete regions of  both longitudinally and 
transversely oriented T-tubules possibly corresponding to 
the region of the junctional complex between T-tubules and 
the  forming junctional SR.  This conclusion is consistent 
with the results of ultrastructural studies, showing that the 
junctional SR does not form a complete terminal cisternae 
along the T-tubules  at this stage of development (34). 
Assuming that the ryanodine receptor is a specific marker 
of the junctional region of the junctional SR (18), the tem- 
poral appearance of triads and T-tubules  was assessed by 
comparing  the  subcellular  distribution  of the  ryanodine 
receptor to that of TS28  and the ~t-DHPR in developing 
rabbit skeletal muscle. Generally, the results presented show 
that the temporal appearance and subcellular distribution of 
the ryanodine receptor are very similar to those of the o~I- 
DHPR but distinct from those of TS28. Thus, in primary and 
secondary myotubes from 19-24-d fet~ rabbit skeletal mus- 
cle the ryanodine receptor is distributed in foci present in the 
outer zone of the cytosol supporting the possibility that the 
ryanodine receptor, like the ot1-DHPR, is a component of 
membrane-bound structures in this region of the cytosol 
(Fig. 8, B/). Since TS28  positive foci are generally absent 
from the outer zone of  the cytosol of 19-24-d fetal myotubes, 
ryanodine receptor positive foci cannot be components of 
triads and are more likely components of membrane-bound 
vesicles either separate from or components of the forming 
SR. Since double labeling for the ryanodine receptor and the 
cxt-DHPR of 24-d fetal myotubes also showed that >80% of 
the foci positively labeled for the ryanodine receptor were 
also positively labeled for the otrDHPR, these results are 
consistent with the idea that most of the aa-DHPR incorpo- 
rated into the TS28-containing T-tubules forming at the cell 
periphery exist in a complex with ryanodine receptors pres- 
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forming SR. Furthermore, these are also consistent with the 
idea that ¢x~-DHPR-positive but TS28-negative  vesicles  in 
the outer zone of the myotubes also form a complex with 
ryanodine  receptors incorporated into either discrete vesi- 
cles (not shown) or into forming  SR. 
The results of double labeling the 1-2-d-old myotubes for 
the  ryanodine  receptor  and  the  ¢xt-DHPR suggested  that 
these two proteins colocalize in foci present in the cytosol. 
Comparison of these results with the results of double label- 
ing for TS28 and the o~t-DHPR suggest that the ot~-DHPR 
incorporated into discrete regions of TS28-contalning  T-tu- 
bules also form a complex with ryanodine  receptors incor- 
porated into  either discrete vesicles or into  forming  SR, 
thus,  forming diad structures between T-tubules and either 
the junctional face of junctional SR or its precursor. 
The  sequence of events  leading  to the incorporation of 
TS28, the ot~-DHPR, and the ryanodine receptor into T-tu- 
bules and triads  is presently unknown.  However, on the ba- 
sis of  our previous studies of the assembly of TS28 into form- 
ing T-tubules  (45),  the results  presented here, and current 
ideas about intracellular  membrane trafficking,  we propose 
the following plausible scheme for the correlation between 
the assembly of (a) TS28 and the ot~-DHPR into T-tubules; 
and  (b)  TS28,  the at-DHPR,  and  the ryanodine  receptor 
into a junctional complex between T-tubules and junctional 
SR (Fig.  8).  First,  otrDHPR (Fig.  8; A/) and ryanodine 
receptors (Fig.  8; B1) are synthesized on membrane-bound 
polyribosomes, incorporated into distinct vesicles, and dis- 
tributed  throughout  the  cytoplasm  (Fig.  8,  A2  and  B2, 
respectively). Next, TS28-containing  vesicles fuse with the 
sarcolemma (Fig. 8, C1 ) thus forming caveolae (Fig. 8, C2). 
Sequential fusions of TS28-contalning  vesicles with forming 
T-tubules (Fig.  8, C4) result in the biogenesis  of T-tubules 
(Fig.  8, C5). As the biogenesis of T-tubules occurs, ryano- 
dine receptor-containing vesicles (Fig. 8, B2) are either (a) 
incorporated into forming SR (Fig.  8, B3) followed by for- 
marion of a complex between ryanodine receptors in the SR 
and  a  o~rDHPR-containing  vesicle (Fig.  8,  AB4);  or (b) 
form a complex with ott-DHPR-containing vesicles in the 
interior region of the cytosol (not shown);  in turn the a,- 
DHPR-contalning vesicle of this  complex fuses with the 
TS28 containing  forming T-tubules (Fig. 8, ABC6), thus in- 
corporating the ot~-DHPR-contalning  vesicle of this  com- 
plex into a discrete region of the forming T-tubules (Fig. 8, 
ABCT). Since the o~t-DHPR is complexed with the ryano- 
dine receptor containing membrane system, incorporation of 
the o~t-DHPR into T-tubules also results in the formation  of 
a junctional complex between T-tubules and the SR. It ap- 
pears from the data presented that the ot~-DHPR does not 
become uniformly distributed along  the forming  T-tubules 
in rabbit  skeletal  muscle until  2  d  after birth.  However, 
the results presented do not permit us to conclude whether 
the ot~-DHPR becomes uniformly distributed throughout the 
T-tubules as development proceeds or remain confined within 
the junctional region of the T-tubules.  Furthermore,  these 
results  do not permit us to conclude whether TS28 in the 
T-tubules becomes a component of the ot~-DHPR contain- 
ing junctional region between T-tubules and junctional SR 
(diads and triads). 
To assess the validity of the scheme proposed for the as- 
sembly of o~-DHPR, TS28, and the ryanodine receptor into 
T-tubules and junctional complexes  between T-tubules and 
junctional SR, it will be important to identify the subcellular 
organelles  in developing  muscle labeled with antibodies  to 
these proteins by immunoelectron microscopy. These studies 
should also be helpful in delineating  the intracellular  path- 
way  taken  by the  organdies  transporting  the  at-DHPR, 
TS28, and the ryanodine receptor from the site of synthesis 
to the site of incorporation into their respective target mem- 
branes. This approach should furthermore determine whether 
the proposed interactions  between the proposed "carrier" or- 
ganelles  indeed occur. 
The scheme proposed for the assembly of T-tubules and 
triads implies that o~l-DHPR-containing vesicles play a piv- 
otal role in the assembly of junctional complexes between 
forming T-tubules and ryanodine  receptor containing junc- 
tional SR. In this regard,  it is interesting  that recent studies 
on dysgenic (mdg/mdg) muscle, an autosomal recessive mu- 
tation  in  mice  characterized  by  the  absence  of  excita- 
tion-contraction coupling (11) and a greatly decreased num- 
ber of triads  (30),  have shown that the otrDHPR, but not 
the ryanodine receptor, is absent from the microsomal frac- 
tion  of dysgenic  muscle (22).  Thus,  developing  dysgenic 
muscle should be an excellent model for testing at the cellu- 
lar level the effect of lack of ~rDHPR on the sequence of 
events leading to the biogenesis of T-tubules and triads  in- 
cluding the effect on intraceUular membrane pathways taking 
TS28 and the ryanodine  receptor from the site of synthesis 
to their target  organeUes. 
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